Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women

被引:0
作者
Sun Min Oh
Byung-Ho Nam
Yumie Rhee
Seong-Hwan Moon
Deog Young Kim
Dae Ryong Kang
Hyeon Chang Kim
机构
[1] Yonsei University College of Medicine,Department of Preventive Medicine
[2] National Cancer Center,Biometric Research Branch
[3] Yonsei University College of Medicine,Department of Internal Medicine, Endocrine Research Institute, and Brain Korea 21 Project for Medical Science
[4] Yonsei University College of Medicine,Department of Orthopedics Surgery
[5] Yonsei University College of Medicine,Department and Research Institute of Rehabilitation Medicine
[6] Yonsei University College of Medicine,Biostatistics Collaboration Unit
[7] Yonsei University College of Medicine,Severance Institute for Vascular and Metabolic Research
[8] Northwestern University Feinberg School of Medicine,Department of Preventive Medicine
来源
Journal of Bone and Mineral Metabolism | 2013年 / 31卷
关键词
Osteoporosis; Risk assessment; Postmenopausal women; Korea;
D O I
暂无
中图分类号
学科分类号
摘要
Currently, dual-energy X-ray absorptiometry (DXA) is the gold standard for detecting osteoporosis, but is not recommended for general population screening. Therefore, this study aims to develop an osteoporosis risk-assessment model to identify high-risk individuals among Korean postmenopausal women. Data from 1,209 and 1,046 postmenopausal women who participated in the 2009 and 2010 Korean National Health and Nutrition Examination Survey, respectively, were used for development and validation of an osteoporosis risk-assessment model. Osteoporosis was defined as T score less than or equal to −2.5 at either the femoral neck or lumbar spine. Performance of the candidate models and the Osteoporosis Self assessment Tool for Asians (OSTA) were compared with respect to sensitivity, specificity, and area under the receiver operating characteristics curve (AUC). To compare the developed Korean Osteoporosis Risk-Assessment Model (KORAM) with OSTA, a net reclassification improvement was further calculated. In the development dataset, the prevalence of osteoporosis was 33.9 %. KORAM, consisting of age, weight, and hormone therapy, had a sensitivity of 91.2 %, a specificity of 50.6 %, and an AUC of 0.709 with a specific cut-off score of −9. Comparable results were shown in the validation dataset: sensitivity 84.8 %, specificity 51.6 %, and AUC 0.682. Additionally, risk categorization with KORAM showed improved reclassification over that of OSTA from 7.4 to 41.7 %. KORAM can be easily used as a pre-screening tool to identify candidates for DXA tests. Further studies investigating cost-effectiveness and replicability in other datasets are required to establish the clinical utility of KORAM.
引用
收藏
页码:423 / 432
页数:9
相关论文
共 176 条
[1]  
Ström O(2011)Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Arch Osteoporos 6 59-155
[2]  
Borgström F(2012)The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008 Osteoporos Int 23 811-820
[3]  
Kanis JA(2012)Burden of osteoporosis in adults in Korea: a national health insurance database study J Bone Miner Metab 30 54-58
[4]  
Compston J(2008)Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions J Clin Densitom 11 163-187
[5]  
Cooper C(2010)Screening for osteoporosis: an update for the U.S. Preventive Services Task Force Ann Intern Med 153 99-111
[6]  
McCloskey EV(2009)Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice Am J Prev Med 36 366-375
[7]  
Jönsson B(1996)Screening for osteopenia and osteoporosis: selection by body composition Osteoporos Int 6 120-126
[8]  
Dawson-Hughes B(1998)Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density Am J Manag Care 4 37-48
[9]  
Looker AC(2000)Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry CMAJ 162 1289-1294
[10]  
Tosteson AN(2002)Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry Gynecol Endocrinol 16 245-250